Assistance Publique - Hôpitaux de Paris (AP-HP), Service d'Imagerie Médicale, Hôpital Henri-Mondor, 51 avenue du Maréchal de Lattre de Tassigny, 94010, Créteil, France.
Université Paris-Est Créteil (UPEC), 94010, Créteil, France.
Cardiovasc Intervent Radiol. 2019 Oct;42(10):1371-1379. doi: 10.1007/s00270-019-02231-8. Epub 2019 May 13.
To evaluate feasibility, efficacy and overall functional success of image fusion guidance during laser-assisted in situ fenestration of aortic stent graft (LISFAS) for endovascular repair of complex aortic aneurysm (complex-EVAR) in a prospective study.
Between September 2016 and July 2018, 20 patients were included and treated with LISFAS for complex-EVAR. Aortic aneurysms were either para-renal (n = 15) or thoraco-abdominal (n = 5) with 57 mm [first quartile: 54; third quartile: 68] median aneurysm diameter in 69 years [68;78] patients. All interventions were performed using the same angiographic system and 3D image fusion software for overlying pre-intervention CTA on per-intervention 2D fluoroscopy with cone-beam CT images to display target vessels ostia.
LISFAS for complex-EVAR with image fusion was performed in all patients, and no endovascular intervention required conversion to an open aortic repair. LISFAS of all target vessels was feasible in 18 patients (90%); 48 fenestrations out of 50 were performed successfully. Two fenestrations failed for renal arteries in two patients. Median ischemic times were as follows: 34 min [25;43] for superior mesenteric artery; 69 min [56;83] for left renal artery; 73 min [36;102] for right renal artery; and 93 min [89;96] for the celiac trunk. Median intervention and fluoroscopy times, iodinated contrast volume and X-ray exposure were 180 min [150;180], 74 min [64;87], 80 mL [59;113] and 338 Gy.cm [259;495], respectively. Efficacy was found in 17 patients (85%) on one-week follow-up CTA: Two patients had type 1 and 3 endoleaks, respectively, that were successfully embolized. Overall functional success was 90%. Median hospitalization stay was 9 days [8, 17]. The 30-day safety analysis was 90% (n = 2 deaths) owing to an undetermined cause and to bowel ischemia after low flow in intensive care unit.
LISFAS using image fusion was feasible, efficient and overall functionally successful for complex-EVAR in this preliminary study.
前瞻性研究评估在主动脉支架移植物腔内修复术(EVAR)中应用图像融合引导激光辅助原位开窗(LISFAS)治疗复杂主动脉瘤(复杂-EVAR)的可行性、疗效和整体功能成功。
2016 年 9 月至 2018 年 7 月,共纳入 20 例患者接受 LISFAS 治疗复杂-EVAR。主动脉瘤位于肾旁(n=15)或胸腹(n=5),中位瘤径 57mm[四分位距(IQR):54;68],患者 69 岁[IQR:68;78]。所有介入均采用相同的血管造影系统和 3D 图像融合软件,对术前 CTA 进行重叠,术中二维透视与锥束 CT 图像融合,显示目标血管开口。
所有患者均成功完成复杂-EVAR 的 LISFAS,无血管内介入需转为开放主动脉修复。18 例患者(90%)的所有目标血管均能进行 LISFAS;50 个目标血管中,48 个成功进行了开窗。2 例患者因肾动脉各有 2 个开窗失败。肠系膜上动脉的平均缺血时间为 34min[IQR:25;43],左肾动脉为 69min[IQR:56;83],右肾动脉为 73min[IQR:36;102],腹腔干为 93min[IQR:89;96]。平均介入和透视时间、碘造影剂用量和 X 射线暴露量分别为 180min[IQR:150;180]、74min[IQR:64;87]、80mL[IQR:59;113]和 338Gy.cm[IQR:259;495]。1 周 CTA 随访发现 17 例患者(85%)疗效满意:2 例患者分别出现 1 型和 3 型内漏,均成功栓塞。整体功能成功率为 90%。中位住院时间为 9 天[8 天,17 天]。30 天安全性分析显示,90%(n=2 例)患者因不明原因和 ICU 低血流引起的肠缺血死亡。
在这项初步研究中,使用图像融合的 LISFAS 治疗复杂-EVAR 是可行、有效和整体功能成功的。